Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
Clinical trial NCT02420392 · COMPLETED
Trial details
- NCT number
- NCT02420392
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.